Article Details
Retrieved on: 2021-06-09 12:04:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ST101 is a first-in-class peptide antagonist of C/EBPβ that is currently in a Phase 1/2 clinical study in patients with advanced unresectable and metastatic ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here